BioSig Technologies, Inc. (BSGM): Price and Financial Metrics

BioSig Technologies, Inc. (BSGM): $1.87

0.08 (-4.10%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

BSGM Price/Volume Stats

Current price $1.87 52-week high $5.00
Prev. close $1.95 52-week low $0.20
Day low $1.74 Volume 181,400
Day high $1.99 Avg. volume 455,984
50-day MA $0.84 Dividend yield N/A
200-day MA $0.84 Market Cap 32.03M

BSGM Stock Price Chart Interactive Chart >


BioSig Technologies, Inc. (BSGM) Company Bio


BioSig Technologies, Inc., a medical device company, engages in developing and commercializing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. The company's proprietary product include precise uninterrupted real-time evaluation of electrograms electrophysiology system, a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures in an electrophysiology laboratory under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.


BSGM Latest News Stream


Event/Time News Detail
Loading, please wait...

BSGM Latest Social Stream


Loading social stream, please wait...

View Full BSGM Social Stream

BSGM Price Returns

1-mo 179.10%
3-mo 334.88%
6-mo 8.09%
1-year -40.63%
3-year -93.55%
5-year -97.06%
YTD -60.63%
2023 13.10%
2022 -81.17%
2021 -42.82%
2020 -34.12%
2019 38.64%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!